MEI Pharma Inc (MEIP)

2.53 -0.01  -0.39% NASDAQ Jul 28, 09:05 USD
View Full Chart
Price Chart
View All MEIP News


View All Events


Date Type Description
09/09/2021 17:00 EST Earnings Calls Q4 2021 Earnings Call
09/09/2021 Earnings Results Q4 2021 Earnings Results
05/06/2021 Earnings Results Q3 2021 Earnings Results
02/04/2021 Earnings Results Q2 2021 Earnings Results
12/16/2020 12:00 EST AGM 2020 Annual General Meeting
11/10/2020 Earnings Results Q1 2021 Earnings Results
09/09/2020 17:00 EST Earnings Calls Q4 2020 Earnings Call
09/09/2020 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer. Geographically, all the business activities function through the region of the United States.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Sep. 09, 2021
  • Last Earnings Release: May. 06, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.